Penumbra's stock loss contrasted with S&P 500 gain on August 22, 2025.
1 report, 1 independent
Updated Aug 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Penumbra's stock loss contrasted with S&P 500 gain on August 22, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Penumbra, a company in the medical instruments sector, is noted to have underperformed the S&P 500 this year.Sub-event
Penumbra's stock loss contrasted with S&P 500 gain on August 22, 2025.1 source
Keep exploring
The entities involved
-
Penumbra
medical device company in Alameda, California
Related events
Coverage
Newest first; wire copies grouped- StockStoryPenumbra (PEN): Buy, Sell, or Hold Post Q2 Earnings? Over the last six months, Penumbra’s shares have sunk to $251.37, producing a disappointing 12.6% loss - a stark contrast to the S&P 500’s 6.4% ga